Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) resulting in improved adverse effects for example drowsiness, although the medical relevance is reduced for most individuals – monitor the individual for adverse effects (e.If individual are unable to resume their standard